These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2283655)

  • 21. Ace inhibition in renal disease: risks and benefits.
    Campanacci L; Fabris B; Fischetti F; Bardelli M; Vran F; Carretta R
    Clin Exp Hypertens; 1993; 15 Suppl 1():173-86. PubMed ID: 8513308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme inhibitors in perspective: an update.
    Burrell LM; Johnston CI
    Aust Fam Physician; 1993 Jul; 22(7):1243-7, 1251, 1255. PubMed ID: 8373316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ACE-inhibition: organ protection as the central aim].
    Z Kardiol; 1998 May; 87(5 Suppl):1-4. PubMed ID: 9698651
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal failure related to angiotensin-converting enzyme inhibitors.
    Textor SC
    Semin Nephrol; 1997 Jan; 17(1):67-76. PubMed ID: 9000551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihypertensive effect of perindopril. Experimental pharmacology].
    Barthelmebs M; Devissaguet M; Imbs JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE; Chainey A; Sirois P; Devissaguet M
    J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ACE inhibitors in kidney diseases--only another antihypertensive agent?].
    Ritz E; Stein G
    Med Klin (Munich); 1994 Sep; 89(9):473-5. PubMed ID: 7968882
    [No Abstract]   [Full Text] [Related]  

  • 28. [Angiotensin-converting-enzyme inhibition in arterial hypertension].
    Waeber B; Nussberger J; Brunner HR
    Wien Med Wochenschr; 1990 Jan; 140(1-2):22-30. PubMed ID: 2408247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
    Sambhi MP; Gavras H; Robertson JI; Smith WM
    West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deterioration of renal function after converting enzyme inhibition in a patient with renal artery stenosis after transplantation.
    Van Son WJ; Donker AJ; Van der Woude FJ; Meijer S; Slooff MJ; Tegzess AM; Van der Slikke LB
    Neth J Med; 1984; 27(1):10-3. PubMed ID: 6324009
    [No Abstract]   [Full Text] [Related]  

  • 32. [Are ACE inhibitors nephroprotective?].
    Hörl WH
    Wien Klin Wochenschr; 1996; 108(12):373-7. PubMed ID: 8767411
    [No Abstract]   [Full Text] [Related]  

  • 33. Converting enzyme activity in regulation of blood pressure and kidney function. A review.
    Piryova B; Girchev R
    Cor Vasa; 1984; 26(6):401-7. PubMed ID: 6098419
    [No Abstract]   [Full Text] [Related]  

  • 34. [What is assured in therapy with angiotensin converting enzyme (ACE) inhibitors?].
    Risler T; Krämer B; Müller GA; Seipel L
    Internist (Berl); 1989 Dec; 30(12):790-6. PubMed ID: 2695488
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment.
    Elliott HL
    Blood Press Suppl; 1994; 2():31-4. PubMed ID: 8061843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experience.
    Materson BJ; Preston RA
    Arch Intern Med; 1994 Mar; 154(5):513-23. PubMed ID: 8122944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiotensin converting enzyme inhibitors and vascular remodelling in arterial hypertension].
    Garnier LF
    Ann Cardiol Angeiol (Paris); 1993 Oct; 42(8):438-44. PubMed ID: 8122853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of screening tests for renovascular hypertension by angiotensin-converting enzyme inhibition.
    Jonker GJ; Huisman RM; de Zeeuw D
    Nephrol Dial Transplant; 1993; 8(9):798-807. PubMed ID: 8255511
    [No Abstract]   [Full Text] [Related]  

  • 40. [The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors].
    Greminger P; Vetter W
    Schweiz Rundsch Med Prax; 1988 Jun; 77(24):673-9. PubMed ID: 3041532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.